• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Model Number SGC0701
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Perforation (2511)
Event Date 08/21/2020
Event Type  Injury  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The two additional devices referenced are filed under separate medwatch report numbers.
 
Event Description
This is filed to report atrial perforation.It was reported that on (b)(6) 2020, a mitraclip procedure was performed to treat mixed mitral regurgitation (mr) with a grade of 4.It was noted that the mr was caused by annular dilatation.Two clips (00410u169 and 00410u109) were successfully implanted, reducing mr to a grade of 1.On (b)(6) 2020, the patient presented to the hospital with severe pulmonary edema.Transthoracic echocardiography (tte) showed that mr had increased to a grade of 3 and a left to right atrial shunt was present.On (b)(6) 2020, an additional tte was performed and showed that both clips were stable on the leaflets.At this time, it was also noted that the patient had developed right sided heart failure, increased left atrial pressure and the annular dilatation had worsened.It was noted that the patient diuretics weren't well controlled which led to an overload of volume.Later that day, the patient underwent a second mitraclip procedure to treat mr with a grade of 3.It was noted that prior to the procedure, the mean pressure gradient was 5mmhg.One clip (00401u113) was implanted, reducing mr to a grade of 1.A closured device was then implanted to treat the left to right shunt.However, after the procedure, it was noted that the patients mean pressure gradient increased to 7mmhg.There was no clinically significant delay in the procedure.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information provided, the reported atrial perforation is the result of procedural conditions.The patient effect of atrial perforation is listed in the mitraclip instructions for use (ifu) as a known possible complication associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design, or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10547466
MDR Text Key207359344
Report Number2024168-2020-07790
Device Sequence Number1
Product Code DRA
UDI-Device Identifier08717648231025
UDI-Public08717648231025
Combination Product (y/n)N
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/25/2021
Device Model NumberSGC0701
Device Catalogue NumberSGC0701
Device Lot Number00623U739
Was Device Available for Evaluation? No
Date Manufacturer Received10/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
IMPLANTED MITRACLIP (X2); IMPLANTED MITRACLIP (X2)
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-